
About


Mayer Brown Adds to Transfer Pricing Team

Looking Forward: Predictions for 2022

IRS CCA Addresses Intercompany Reimbursements of Branded Prescription Drug Fee: Guidance May be Relevant to Taxpayers Across Industries with Material Non-Deductible Expenses

Profitability Threshold

The Elusive “Amount A”

Intercompany Services: The Next Frontier of Transfer Pricing Disputes

What Are You Worth?

The Vanishing U.S. Comparable
